# Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery

> **NCT04687800** · PHASE4 · TERMINATED · sponsor: **Cathleen McCabe MD** · enrollment: 1 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Dextenza 0.4mg intracanalicular Insert
- **DRUG:** Durezol 0.05% Ophthalmic Emulsion

## Key facts

- **NCT ID:** NCT04687800
- **Lead sponsor:** Cathleen McCabe MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Inability to enroll due to lack of access to the Ambulatory Surgery Center.
- **Last updated:** 2022-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04687800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04687800, "Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04687800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*